Prevalence of HFE (hemochromatosis gene) mutations in unselected male patients with type 2 diabetes

Journal of Laboratory and Clinical Medicine

Volumn 135, Issue 2, 2000, Pages 170-173

  Sampson, Michael J ^a,b   Williams, Tracey ^a   Heyburn, Philip J ^a   Greenwood, Richard H ^a   Temple, Rosemary C ^a   Wimperis, Jennie Z ^a   Jennings, Barbara A ^a   Willis, Gavin A ^a  

^a Norwich Healthcare NHS Trust   (United Kingdom)

^b NORFOLK AND NORWICH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; DNA; GENE MUTATION; HEMOCHROMATOSIS; HETEROZYGOSITY; HOMOZYGOSITY; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; RESTRICTION ENZYME ANALYSIS;

EID: 0034142276     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1067/mlc.2000.104464     Document Type: Article

References (27)

1. 1. Edwards CQ, Kushner JP. Screening for hemochromatosis. N Engl J Med 1993;328:1616-20.
2. 2. Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJH. Global prevalence of putative hemochromatosis mutations. J Med Genet 1997;34:275-8.
3. 3. Willis G, Wimperis JZ, Lonsdale R, Jennings BA. hemochromalosis gene mutation in hepatocellular cancer. Lancet 1997;350:565-6.
4. 4. Willis G, Jennings BA, Goodman E, Fellows IW, Wimperis JZ. A high prevalence of HLA-H 845A mutations in hemochromatosis patients and the normal population in eastern England. Blood Cell Mol Dis 1997;23:288-91.
5. 5. Gollan JL. Diagnosis of hemochromatosis. Gastroenterology 1983;84:418-21.
6. 6. Coller SJ, Lin M, Carlson TH, Bronner MP, Labbe RF, Perkins JD, et al. Serum iron studies do not identify patients with end stage liver disease. Gastroenterology 1996;110: A1175.
7. 7. Rosner IA, Askari AD, McLaren GD, Muir A. Arthropathy, hypouricemia and normal serum iron studies in hereditary hemochromatosis. Am J Med 1981;70:870-4.
8. 8. Bassett ML, Halliday JW, Ferris RA, Powell LW. Diagnosis of hemochromatosis in young subjects: predictive accuracy of biochemical screening tests. Gastroenterology 1984;87: 628-33.
9. 9. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis. Nat Genet 1996;13:399-408.
10. 10. Turnbull AJ, Mitchison HC, Peaston RTP, Lai LC, Bennett MK, Taylor R, et al. The prevalence of hereditary hemochromatosis in a diabetic population. Q J Med 1997;90:271-5.
11. 11. O'Brien T, Barrett B, Murray DM, Dineen S, O'Sullivan DJ. Usefulness of biochemical screening of diabetic patients for hemochromatosis. Diabetes Care 1990;13:532-34.
12. 12. Singh BM, Grunewald RA, Press M, Muller BR, Wise PH. Prevalence of hemochromatosis amongst patients with diabetes mellitus. Diabet Med 1992;9:730-1.
13. 13. Moirand R, Adams PC, Bicheler V, Brissot P, Deugnier Y. Clinical features of genetic hemochromatosis in women compared with men. Ann Intern Med 1997;127:105-10.
14. 14. George DK, Evans RM, Crofton RW, Gunn IR. Testing for hemochromatosis in the diabetic clinic. Ann Clin Biochem 1995;32:521-6.
15. 15. Phelps G, Chapman I, Hall P, Braund W, Mackinnon M. Prevalence of genetic hemochromatosis among diabetic patients [comment]. Lancet 1989;2:233-4
16. 16. Balan V, Baldus W, Fairbanks V, Michels V, Burritt M, Klee G. Screening for hemochromatosis: a cost-effectiveness study based on 12,258 patients. Gastroenterology 1994;107: 453-9.
17. 17. Conte D, Manachino D, Colli A, Guala A, Aimo G, Andreoletti M, et'al. Prevalence of genetic hemochromatosis in a cohort of Italian patients with diabetes mellitus. Ann Intern Med 1998;128:370-3.
18. 18. Kaye TB, Guay AT, Simonson DC. Non-insulin dependent diabetes mellitus and elevated serum ferritin level. J Diabetes Complications 1993;7:246-9.
19. 19. Frayling T, Ellard S, Grove J, Walker M, Hattersley AT. C282Y mutation in HFE (hemochromatosis) gene and type 2 diabetes Lancet 1998;351:1933-4.
20. 20. Braun J, Donner H, Plock K, Rau H, Usadel KH, Badenhoop K. Hereditary hemochromatosis mutations (HFE) in patients with type 2 diabetes mellitus. Diabetologia 1998;41:983.
21. 22. Behn PS, Glaser B, Permutt A. Contribution of the C282Y hereditary haemochromatosis mutation to type 2 diabetes mellitus in Ashkenazi Jews. Diabetes 1998;47(suppl 1):1523.
22. 23. Rasmussen S, Echwald S, Hansen L, et al. Analysis of the relationship between a common Cys 282Tyr variant of the hereditary haemochromatosis gene and NIDDM. Diabetologia 1997;40:S1653.
23. 24. Kwan T, Leber B, Ahuja S, Carter R, Gerstein HC. Patients with type 2 diabetes have a high frequency of the C282Y mutation of the haemochromatosis gene. Clin Invest Med 1998:21:252-7.
24. 25. Fernandez-Real JM, Vendrell J, Baiget M, Gimferrer E, Ricart W. C282Y and H63D mutations of the haemochromatosis candidate gene in type 2 diabetes. Diabetes Care 1999;22:525.
25. 26. Dubois-Laforgue D, Caillat-Zucman S, Djilali-Saiah I, et al. Mutations in HFE, the haemochromatosis candidate gene, in patients with NIDDM. Diabetes Care 1998;21:1371-2.
26. 27. Inoue Y, Nakanishi K, Hiraga T, Okubo M, Murase T, Kosaka K, et al. Recovery of pancreatic beta-cell function in hemochromatosis: combined treatment with recombinant human erythropoietin and phlebotomy. Am J Med Sci 1997;314:401-2.
27. 28. Frayling T, Ellard S, Ayres S, Ayres R, Hattersley AT. Letter. Lancet 1998;352:1068. caused by secondary effects of unknown regulator(s) other than sitosterol. (J Lab Clin Med 2000;135:174-9)